intelliris.com
The Head of Ministry of Industry and Trade Denis Manturov stated that sanctions aided the growth of pharmaceutical manufacturing in Russia | Analytics Intelliris
http://www.intelliris.com/analytics/the-head-of-ministry-of-industry-and-trade-denis-manturov-stated-that-sanctions-aided-the-growth-of-pharmaceutical-manufacturing-in-russia.html
The Head of Ministry of Industry and Trade Denis Manturov stated that sanctions aided the growth of pharmaceutical manufacturing in Russia. INTELLIRIS LLC, 119048, Moscow, Efremova St, 14 office B, 7 (495) 374-82-48, info@intelliris.com.
intelliris.com
Ernst&Young published a study «The Russian pharmaceutical industry amid economic sanctions» | Analytics Intelliris
http://www.intelliris.com/analytics/ernst-i-young-published-a-study-«the-russian-pharmaceutical-industry-amid-economic-sanctions».html
Ernst&Young published a study The Russian pharmaceutical industry amid economic sanctions. Sources: Ernst&Young, Pharmvestnik. INTELLIRIS LLC, 119048, Moscow, Efremova St, 14 office B, 7 (495) 374-82-48, info@intelliris.com.
intelliris.com
About us Intelliris
http://www.intelliris.com/about.html
There is nothing more criminal and self-destructive than having a great idea and then putting it off. The name Intelliris comes from a combination of two latin roots (intel intelligent and iris eye, pupil). It means intelligent, farsighted view. This is what our company offers to client in the healthcare industry our knowledge, experience, expert assessment and insights will aid your decision-making process. Why you should work with us. All of our employees have years worked in international pharmaceutic...
intelliris.com
Analytics Intelliris
http://www.intelliris.com/analytics
Russian pharmaceutical market amounted to 1.25 trillion rubles (in consumer prices including VAT) and 5.1 billion packs in 2015. The market grew 8.2% in rubles but lost 4.4% of its volume. The value decline was more pronounced in USD (-32% vs. 2014). Market downfall is inversely related to USD-ruble exchange rate growth in 2015 ( 59% vs. 2014). Drug prices grew an average of 10.3% in rubles, which is lower than the 12.91% inflation for the market as a whole.…. Pfizer and Allergan announced their merger.
intelliris.com
Lupin acquired ZAO «Biokom» from SIA international | Analytics Intelliris
http://www.intelliris.com/analytics/lupin-acquired-zao-«biochom»-from-sia-international.html
Lupin acquired ZAO Biokom from SIA international. The deal marks the entry of the third largest pharmaceutical company in India into Russia. Lupin is also the third largest supplier of generics to the US. Generics manufacturer Biokom was founded in 1991. Its turnover reached 861.2 million rubles in 2014, according to Lupin. Sources: http./ www.lupin.com, Pharmvestnik, EvaluatePharma. INTELLIRIS LLC, 119048, Moscow, Efremova St, 14 office B, 7 (495) 374-82-48, info@intelliris.com.
intelliris.com
Projects Intelliris
http://www.intelliris.com/projects
Projects listed below are just a few of those we are currently working on. If you are would like to get more information or include your business development needs on our site please contact us at info@intelliris.com. Or 7 (910) 401-30-17. Products available for in-licensing in Russia and CIS. An isotonic nasal solution with dexpanthenol, dosed at 5%. Can be used by children from 2 years onwards as well as adults. Apart from the decongestant and cleaning actions,. Classified as a Medical Device class III.
intelliris.com
Partners Intelliris
http://www.intelliris.com/partners.html
INTELLIRIS LLC, 119048, Moscow, Efremova St, 14 office B, 7 (495) 374-82-48, info@intelliris.com.
intelliris.com
Our services Intelliris
http://www.intelliris.com/services
Portfolio and strategy analysis, market analytics. Evaluating portfolio potential for the market of Russion Federation, assessment of various entry models and turnkey implementation of the model chosen. Testing product concept and commercialization ability with thought leaders and retailers. Market entry model proposal. Definition of potential partner criteria, selection and introduction of distributors optimal for company products. Tender and state purchases analysis. Registration dossier assessment, re...
